MARKET

PFE

PFE

Pfizer
NYSE
27.42
-0.13
-0.45%
After Hours: 27.40 -0.02 -0.05% 16:01 11/20 EST
OPEN
27.83
PREV CLOSE
27.54
HIGH
28.11
LOW
27.36
VOLUME
26.71M
TURNOVER
--
52 WEEK HIGH
30.99
52 WEEK LOW
22.76
MARKET CAP
156.26B
P/E (TTM)
39.20
1D
5D
1M
3M
1Y
5Y
1D
Pfizer Advances RSV Booster Study in Older Adults
TipRanks · 7h ago
5 High-Yield Dividend Stocks Retirees Can Buy for Under $50 a Share
24/7 Wall St. · 8h ago
Cboe data shows mixed options sentiment in Pfizer with shares up 1.18%
TipRanks · 8h ago
4 Dividend Stocks Wall Street Gave Up On With Balance Sheets Built to Recover
24/7 Wall St. · 9h ago
Pfizer Yields 6.25%. These 3 Dividend Stocks Pay More Than a 1-Year Treasury Bill
24/7 Wall St. · 9h ago
4 Yield Traps Paying Over 6% That Retirees Should Watch Out For
24/7 Wall St. · 9h ago
Vertex Pharmaceuticals: Look For Povetacicept Approval In 2 Weeks As Next Catalyst
Seeking Alpha · 11h ago
Medical Properties Trust Yields 22%, but Its Stock Has Crashed 65%
24/7 Wall St. · 11h ago
More
About PFE
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.

Webull offers Pfizer Inc stock information, including NYSE: PFE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PFE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PFE stock methods without spending real money on the virtual paper trading platform.